Regular Human Insulin
Regular Human Insulin is a pharmaceutical drug with 15 clinical trials. Historical success rate of 92.3%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
3
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
92.3%
12 of 13 finished
7.7%
1 ended early
0
trials recruiting
15
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Memory Aid by Intranasal Insulin in Diabetes (MemAID)
Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery
Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery
An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 2 Diabetes Mellitus
An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus
Clinical Trials (15)
Memory Aid by Intranasal Insulin in Diabetes (MemAID)
Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery
Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery
An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 2 Diabetes Mellitus
An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus
Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.
A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro
Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus
Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro Alone
Healthy Normal Volunteers Looking at Exposure and Effects of Multiple Doses of Technosphere® Insulin (TI) Using the Gen2C Inhaler
Comparison of the Effect on the Glucose Infusion Rates Between Inhaled Technosphere Insulin and a Subcutaneous Injection of Regular Human Insulin
Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study
Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin
Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes
A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition
All 15 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 15